Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

487 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.
Kooyker AI, Toes-Zoutendijk E, Opstal-van Winden AWJ, Spaander MCW, Buskermolen M, van Vuuren HJ, Kuipers EJ, van Kemenade FJ, Ramakers C, Thomeer MGJ, Dekker E, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I. Kooyker AI, et al. Among authors: de koning hj. Int J Cancer. 2020 Aug 15;147(4):1098-1106. doi: 10.1002/ijc.32839. Epub 2020 Jan 9. Int J Cancer. 2020. PMID: 31853977 Free PMC article.
Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.
de Koning HJ, Auvinen A, Berenguer Sanchez A, Calais da Silva F, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schröder FH; European Randomized Screening for Prostate Cancer (ERSPC) Trial; International Prostate Cancer Screening Trials Evaluation Group. de Koning HJ, et al. Int J Cancer. 2002 Jan 10;97(2):237-44. doi: 10.1002/ijc.1588. Int J Cancer. 2002. PMID: 11774270 Free article. Clinical Trial.
Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Kriege M, Brekelmans CT, Boetes C, Muller SH, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Rutgers EJ, de Koning HJ, Klijn JG; Dutch MRI Screening (MRISC) Study Group. Kriege M, et al. Among authors: de koning hj. Cancer. 2006 Jun 1;106(11):2318-26. doi: 10.1002/cncr.21863. Cancer. 2006. PMID: 16615112 Free article.
Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).
van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, Prokop M, Habbema JD, Oudkerk M, van Klaveren RJ. van Iersel CA, et al. Among authors: de koning hj. Int J Cancer. 2007 Feb 15;120(4):868-74. doi: 10.1002/ijc.22134. Int J Cancer. 2007. PMID: 17131307 Free article. Clinical Trial.
Breast cancer screening: evidence for false reassurance?
de Gelder R, van As E, Tilanus-Linthorst MM, Bartels CC, Boer R, Draisma G, de Koning HJ. de Gelder R, et al. Among authors: de koning hj. Int J Cancer. 2008 Aug 1;123(3):680-6. doi: 10.1002/ijc.23540. Int J Cancer. 2008. PMID: 18484587 Free article.
487 results